ArticleCardiovascular diabetology. Endocrinology reports2026
Effects of empagliflozin on cardiac function and cardiorespiratory fitness in people with type 2 diabetes: a randomised controlled trial.
Natalie Nanayakkara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.